Mills EA - Search Results

1

Siponimod Attenuates Neuronal Cell Death Triggered by Neuroinflammation via NFκB and Mitochondrial Pathways.

Gurrea-Rubio M, Wang Q, Mills EA, Wu Q, Pitt D, Tsou PS, Fox DA, Mao-Draayer Y. Gurrea-Rubio M, et al. Among authors: mills ea. Int J Mol Sci. 2024 Feb 20;25(5):2454. doi: 10.3390/ijms25052454. Int J Mol Sci. 2024. PMID: 38473703 Free PMC article.

2

Siponimod enriches regulatory T and B lymphocytes in secondary progressive multiple sclerosis.

Wu Q, Mills EA, Wang Q, Dowling CA, Fisher C, Kirch B, Lundy SK, Fox DA, Mao-Draayer Y; AMS04 Study Group. Wu Q, et al. Among authors: mills ea. JCI Insight. 2020 Feb 13;5(3):e134251. doi: 10.1172/jci.insight.134251. JCI Insight. 2020. PMID: 31935197 Free PMC article.

3

Understanding Progressive Multifocal Leukoencephalopathy Risk in Multiple Sclerosis Patients Treated with Immunomodulatory Therapies: A Bird's Eye View.

Mills EA, Mao-Draayer Y. Mills EA, et al. Front Immunol. 2018 Feb 2;9:138. doi: 10.3389/fimmu.2018.00138. eCollection 2018. Front Immunol. 2018. PMID: 29456537 Free PMC article. Review.

4

Aging and lymphocyte changes by immunomodulatory therapies impact PML risk in multiple sclerosis patients.

Mills EA, Mao-Draayer Y. Mills EA, et al. Mult Scler. 2018 Jul;24(8):1014-1022. doi: 10.1177/1352458518775550. Epub 2018 May 18. Mult Scler. 2018. PMID: 29774781 Free PMC article. Review.

5

Impact of trial design and patient heterogeneity on the identification of clinically effective therapies for progressive MS.

Mills EA, Begay JA, Fisher C, Mao-Draayer Y. Mills EA, et al. Mult Scler. 2018 Dec;24(14):1795-1807. doi: 10.1177/1352458518800800. Epub 2018 Oct 10. Mult Scler. 2018. PMID: 30303445 Free PMC article.

6

Elevated sCD40L in Secondary Progressive Multiple Sclerosis in Comparison to Non-progressive Benign and Relapsing Remitting Multiple Sclerosis.

Wu Q, Wang Q, Yang J, Martens JW, Mills EA, Saad A, Chilukuri P, Dowling CA, Mao-Draayer Y. Wu Q, et al. Among authors: mills ea. J Cent Nerv Syst Dis. 2021 Oct 25;13:11795735211050712. doi: 10.1177/11795735211050712. eCollection 2021. J Cent Nerv Syst Dis. 2021. PMID: 34720605 Free PMC article.

7

Teriflunomide modulates both innate and adaptive immune capacities in multiple sclerosis.

Wu Q, Wang Q, Yang J, Mills EA, Chilukuri P, Saad A, Dowling CA, Fisher C, Kirch B, Mao-Draayer Y. Wu Q, et al. Among authors: mills ea. Mult Scler Relat Disord. 2023 Jul;75:104719. doi: 10.1016/j.msard.2023.104719. Epub 2023 Apr 16. Mult Scler Relat Disord. 2023. PMID: 37172367

8

Dysregulation of humoral immunity, iron homeostasis, and lipid metabolism is associated with multiple sclerosis progression.

Wang Q, Wu Q, Yang J, Saad A, Mills E, Dowling C, Lundy S, Mao-Draayer Y. Wang Q, et al. Mult Scler Relat Disord. 2023 Nov;79:105020. doi: 10.1016/j.msard.2023.105020. Epub 2023 Sep 24. Mult Scler Relat Disord. 2023. PMID: 37806231

9

Emerging Approaches for Validating and Managing Multiple Sclerosis Relapse.

Mills EA, Mirza A, Mao-Draayer Y. Mills EA, et al. Front Neurol. 2017 Mar 29;8:116. doi: 10.3389/fneur.2017.00116. eCollection 2017. Front Neurol. 2017. PMID: 28424654 Free PMC article. Review.

10

Emerging Understanding of the Mechanism of Action for Dimethyl Fumarate in the Treatment of Multiple Sclerosis.

Mills EA, Ogrodnik MA, Plave A, Mao-Draayer Y. Mills EA, et al. Front Neurol. 2018 Jan 23;9:5. doi: 10.3389/fneur.2018.00005. eCollection 2018. Front Neurol. 2018. PMID: 29410647 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Search Page

Filters